4//SEC Filing
Dispersyn Gerrit 4
Accession 0001209191-20-015801
CIK 0001533040other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:27 PM ET
Size
5.3 KB
Accession
0001209191-20-015801
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Tax Payment
Common stock, $0.0001 par value
2020-03-01$2.93/sh−673$1,972→ 14,628 total
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001704417
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:27 PM ET
- Size
- 5.3 KB